Letter by Feng et al Regarding Article, “Ischemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin: Impact of Quality of Anticoagulation Control”

We read with interest the excellent work by Ho et al1 investigating the real-world anticoagulation experience of Chinese population with atrial fibrillation (AF). We agreed with the authors that, In Chinese patients with atrial fibrillation, the benefits of warfarin therapy for stroke prevention and ICH risk are closely dependent on the quality of anticoagulation. The data in the article showed that …